Trials / Completed
CompletedNCT03514680
Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy
Evaluating a Clinician Support Algorithm to Enhance Implementation of Evidence-Based Chemotherapy-Induced Peripheral Neuropathy Assessment and Management Recommendations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 226 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This research study is evaluating how well a decision support tool works to improve clinicians' use of recommended chemotherapy-induced peripheral neuropathy (CIPN) assessment and management strategies in participants receiving chemotherapy.
Detailed description
This research study will test a new clinician decision support tool for the assessment and management of CIPN. The algorithm is designed to help clinicians make decisions about which strategies to use for the assessment and/or management of CIPN. The investigators need to recruit participants receiving chemotherapy that is known to cause CIPN to determine how well the algorithm works to increase clinicians' use of recommended CIPN assessment and management strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | CIPN Assessment and Management Algorithm | The revised algorithm incorporates evidence-based CIPN assessment and management strategies and standardized CIPN/pain patient-reported outcomes measures. In terms of processes, trained study staff will administer the screening questionnaires (e.g., PRO-CTCAE, 0 - 10 numerical rating scale of worst CIPN pain intensity) to consented patients before their clinician visit (e.g., in the waiting room). Following patient completion of the screening questionnaires, study staff will provide the clinicians with a color-coded summary of the patients' responses to the screening questionnaires and the CIPN assessment and management algorithm. Clinicians may then use the algorithm at their discretion to guide the assessment and management of their patients' CIPN symptoms |
Timeline
- Start date
- 2018-06-04
- Primary completion
- 2019-12-30
- Completion
- 2020-03-23
- First posted
- 2018-05-02
- Last updated
- 2022-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03514680. Inclusion in this directory is not an endorsement.